SMTL ID : 4jlm.1

Human dCK C4S-S74E mutant in complex with UDP and the F2.3.1 inhibitor (2-[({5-ETHYL-2-[3-(2-FLUOROETHOXY)-4-METHOXYPHENYL]-1,3-THIAZOL-4-YL}METHYL)SULFANYL]PYRIMIDINE-4,6-DIAMINE)

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.18 Å
Oligo State
homo-dimer
Ligands
3 x 1NN: 2-[({5-ethyl-2-[3-(2-fluoroethoxy)-4-methoxyphenyl]-1,3-thiazol-4-yl}methyl)sulfanyl]pyrimidine-4,6-diamine(Non-covalent)(Covalent)
2 x UDP: URIDINE-5'-DIPHOSPHATE(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Nomme, J. et al., Structural characterization of new deoxycytidine kinase inhibitors rationalizes the affinity-determining moieties of the molecules. Acta Crystallogr.,Sect.D (2014)
Release Date
2014-01-22
Peptides
Deoxycytidine kinase: AB
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

Deoxycytidine kinase

Toggle Identical (AB)

Related Entries With Identical Sequence

4jlj.1 | 4jlk.1 | 4jln.1 | 4kcg.1 | 4l5b.1 | 4q18.1 | 4q19.1 | 4q1a.1 | 4q1b.1 | 4q1c.1 | 4q1d.1 | 4q1e.1 | 4q1f.1 | 7zi1.1 | 7zi2.1 | 7zi3.1 | 7zi5.1 | 7zi6.1 | 7zi7.1 | 7zi8.1 | 7zi9.1 | 7zia.1 | 7zib.1 | 8ooj.1 | 8ooj.2 | 8ooj.3